If you can see through the illusion, you are part of the solution
Subscribe to access subscriber only items and receive notification of new items
The evaluation of the Comirnaty vaccine was significantly expedited without compromising the TGA’s strict standards of safety, quality and efficacy. This was facilitated through rolling data submission, and through collaboration with international regulators. The provisional determination for the Pfizer-BioNTech COVID-19 vaccine, BNT162b2 (mRNA) was granted by TGA on 14 October 2020. Facial paralysis: there were Read More …
COMIRNATY is a vaccine given to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adults and adolescents from 16 years of age and older. COMIRNATY contains the active ingredient BNT162b2 [mRNA]. 4 pages. 15 pages If you can spare a few dollars for the creators of this Read More …
VAERS Data Sets VAERS data CSV and compressed (ZIP) files are available for download in the table below. For information about VAERS data, please view the VAERS Data Use Guide[PDF – 310KB], which contains the following information: Important information about VAERS from the FDA Brief description of VAERS Cautions on interpreting VAERS data Definitions of Read More …
The word “vaccine” originates from the Latin Variolae vaccinae (cowpox), which Edward Jenner demonstrated in 1798 could prevent smallpox in humans. Today the term ‘vaccine’ applies to all biological preparations, produced from living organisms, that enhance immunity against disease and either prevent (prophylactic vaccines) or, in some cases, treat disease (therapeutic vaccines). Vaccines are administered Read More …
The Moderna and Pfizer “alleged vaccine” trials have explicitly acknowledged that their gene therapy technology has no impact on viral infection or transmission whatsoever and merely conveys to the recipient the capacity to produce an S1 spike protein endogenously by the introduction of a synthetic mRNA sequence. 205 pages. If you can spare Read More …
Carcinogenicity GARDASIL has not been evaluated for carcinogenic potential. Genotoxicity GARDASIL has not been evaluated for genotoxic potential. Paediatric Use The safety and efficacy of GARDASIL have not been evaluated in children younger than 9 years. Use with Other Vaccines Results from clinical studies indicate that GARDASIL may be administered concomitantly (at a separate Read More …
Australia was the first country to introduce a government-funded National Human Papillomavirus (HPV) Vaccination Program for females. From 2007 to 2012, the TGA captured national adverse event reports via routine passive surveillance. In 2013, the National Immunisation Program (NIP) schedule was extended to include males (12 to 13 years as standard and a two year Read More …
Health Ministry: ‘It’s not an experiment’ ‘It’s an aggregate information-sharing agreement with Pfizer,’ Health Ministry responds to Helsinki Committee report. The Health Ministry tonight responded to reports that the Helsinki Committee for Human Rights is expected to announce that Pfizer is conducting unauthorized human experimentsin Israel. In a statement, the Ministry said “in an Read More …
6 ADVERSE REACTIONS 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a vaccine cannot be directly compared to rates in the clinical trials of another vaccine and may not reflect the rates observed in practice. Vaccine-related adverse reactions reported during clinical Read More …
When INFANRIX hexa must not be given INFANRIX hexa should not be given if your child has had an allergic reaction to: • INFANRIX hexa or any of the active ingredients in the vaccine • any of the ingredients listed at the end of this leaflet. • any other diphtheria, tetanus, hepatitis B, inactivated polio Read More …